GWM
RGEN icon

Geneos Wealth Management’s Repligen RGEN Stock Holding History

Geneos Wealth Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-146
Closed -$18.2K – 3032
2025
Q2 		$18.2K Sell
146
-20
-12% -$2.54K ﹤0.01% 2074
2025
Q1 		$21.1K Buy
166
+126
+315% +$19.4K ﹤0.01% 1921
2024
Q4 		$5.76K Sell
40
-6
-13% -$860 ﹤0.01% 2284
2024
Q3 		$6.85K Sell
46
-4
-8% -$574 ﹤0.01% 1959
2024
Q2 		$6.3K Sell
50
-110
-69% -$17.2K ﹤0.01% 1667
2024
Q1 		$29.4K Hold
160
– – ﹤0.01% 1251
2023
Q4 		$28.8K Sell
160
-129
-45% -$20.1K ﹤0.01% 1241
2023
Q3 		$46K Buy
289
+4
+1% +$654 ﹤0.01% 1104
2023
Q2 		$40.3K Sell
285
-25
-8% -$4.01K ﹤0.01% 1144
2023
Q1 		$52.2K Hold
310
– – ﹤0.01% 1066
2022
Q4 		$52.5K Sell
310
-185
-37% -$33.6K ﹤0.01% 1041
2022
Q3 		$92K Sell
495
-185
-27% -$39K 0.01% 832
2022
Q2 		$113K Hold
680
– – 0.01% 971
2022
Q1 		$127K Sell
680
-125
-16% -$23.7K 0.01% 993
2021
Q4 		$213K Hold
805
– – 0.01% 834
2021
Q3 		$226K Hold
805
– – 0.01% 807
2021
Q2 		$162K Sell
805
-40
-5% -$7.76K 0.01% 945
2021
Q1 		$178K Sell
845
-40
-5% -$8.2K 0.01% 1019
2020
Q4 		$155K Buy
+885
New +$161K 0.01% 934
2017
Q2 		– Sell
-400
Closed -$14K – 2126
2017
Q1 		$14K Hold
400
– – ﹤0.01% 1372
2016
Q4 		$12K Hold
400
– – ﹤0.01% 1386
2016
Q3 		$12K Hold
400
– – ﹤0.01% 1311
2016
Q2 		$11K Hold
400
– – ﹤0.01% 1298
2016
Q1 		$10K Buy
+400
New +$9.79K ﹤0.01% 1311

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Geneos Wealth Management's RGEN Position: Q3 2025 in Review

Geneos Wealth Management sold out of Repligen (RGEN) in Q3 2025, closing a stake of 146 shares — an estimated $18.2K sold.

Geneos Wealth Management first reported a position in RGEN in Q1 2016 and held it in 24 quarters. The position peaked at $226K in Q3 2021. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Geneos Wealth Management reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 146 Repligen shares in Q3 2025, an estimated $18.2K.
  • Geneos Wealth Management first reported a position in Repligen in Q1 2016 and held it in 24 quarters.
  • Geneos Wealth Management's Repligen position peaked at $226K in Q3 2021.
  • 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.